Authors: WoldeMussie, E Ruiz, G Wijono, M Wheeler, LA

Citation: E. Woldemussie et al., Neuro-protection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension, INV OPHTH V, 42(12), 2001, pp. 2849-2855

Authors: Hare, WA Ton, H Ruiz, G Feldmann, B Wijono, M WoldeMussie, E

Citation: Wa. Hare et al., Characterization of retinal injury using ERG measures obtained with both conventional and multifocal methods in chronic ocular hypertensive primates, INV OPHTH V, 42(1), 2001, pp. 127-136

Authors: Hare, W WoldeMussie, E Lai, R Ton, H Ruiz, G Feldmann, B Wijono, M Chun, T Wheeler, L

Citation: W. Hare et al., Efficacy and safety of memantine, an NMDA-Type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat andmonkey, SURV OPHTHA, 45, 2001, pp. S284-S289

Authors: Wheeler, LA Gil, DW WoldeMussie, E

Citation: La. Wheeler et al., Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma, SURV OPHTHA, 45, 2001, pp. S290-S294

Authors: Schori, H Kipnis, J Yoles, E WoldeMussie, E Ruiz, G Wheeler, LA Schwartz, M

Citation: H. Schori et al., Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma, P NAS US, 98(6), 2001, pp. 3398-3403

Authors: Gil, D Spalding, T Kharlamb, A Skjaerbaek, N Uldam, A Trotter, C Li, DH WoldeMussie, E Wheeler, L Brann, M

Citation: D. Gil et al., Exploring the potential for subtype-selective muscarinic agonists in glaucoma, LIFE SCI, 68(22-23), 2001, pp. 2601-2604